OKYO director Brancaccio holds 30,201 shares
OKYO Pharma Ltd director John P. Brancaccio has filed an initial ownership report showing his equity position in the company.
Rhea-AI Filing Summary
OKYO Pharma Ltd director John P. Brancaccio has filed an initial ownership report showing his equity position in the company. He directly holds 30,201 shares of common stock, plus multiple option awards over OKYO common shares with exercise prices between $1.46 and $2.13 per share and expirations ranging from 2033 to 2035. These options vest in staggered annual tranches from 2024 through 2029, giving him long‑term, option-based exposure in addition to his current shareholdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
24 transactions reported
Mixed
24 txns
Insider
BRANCACCIO JOHN P
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | COMMON STOCK | -- | -- | -- |
Holdings After Transaction:
Options — 131,894 contracts (Direct);
COMMON STOCK — 30,201 shares (Direct)
AI-generated analysis. How Rhea-AI works. Not financial advice.
